Quick Asked: Cytomx Therapeutics Contact Us?
Last update: 11 Apr, 2024 
117 Views
What is cytomx therapeutics? CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.Who is cycytomx and cx 188? CytomX is responsible for the IND filing, targeted for late 2021, and for early clinical development with Amgen leading later stage development and commercialization. CX-188 is our wholly owned PD-1-targeting Probody therapeutic.Why work at cycytomx? CytomX is an equal opportunity employer and does not discriminate against any inpidual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category. "Our work is very meaningful here because we have a direct way of impacting the quality of life for our patients."What is cytomxs cx 2029? CytomX and AbbVie are co-developing CX-2029, a PDC directed against CD71, the transferrin receptor that is highly expressed on a number of solid and hematologic tumors, as well as many normal tissues. CytomX is evaluating CX-2029 in a Phase 1/2 clinical trial as monotherapy.